- Xometry Inc (NASDAQ:XMTR) reported second-quarter FY22 sales growth of 89% year-on-year, to $95.62 million, beating the consensus of $93.08 million.
- Marketplace Active Buyers increased 40% to 33,491 as of June 30, 2022.
- The gross profit for the quarter rose 217% Y/Y to $37.7 million with a gross margin of 39.4%.
- The loss from operations widened to $(15.6) million. Adjusted EBITDA loss for the quarter was $(8.3) million.
- The company held $356.7 million in cash and equivalents as of June 30, 2022.
- Adjusted loss per share for the quarter narrowed to $(0.18) versus $(1.14) a year ago.
- Outlook: Xometry sees FY22 revenue of $395 million – $400 million (prior view $392.0 million – $400.0 million) versus the estimate of $397.09 million. Adjusted EBITDA loss of $(33) million – $(31) million (prior view $(36.0) million – $(32.0) million.
- The company expects Q3 revenue of $102 million – $104 million versus the estimate of $103.90 million. Adjusted EBITDA loss of $(7) million – $(6) million.
- Price Action: XMTR shares are trading higher by 21.1% at $50.79 on the last check Wednesday.
Lifeward CEO Issues Open Letter To Shareholders On Progress To Finalize Exoskeleton Medicare Payment Rate
Collaboration with CMS on final payment rate focuses on commercial transaction values for the latest generation of ReWalk Exoskeleton CMS indicates that recently issued fee schedule which omitted exoskeletons can be